CIK 0001237831 · Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043744954
- Phone
- 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,970,014
- in 4 filings, $425K under 10b5-1 plans
Net −$7,970,014. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-23 | Paul David C Executive Chairman | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +75,000 | 75,000 | ||
| 2025-01-23 | Pfeil Keith W COO, CFO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +60,000 | 60,000 | ||
| 2025-01-23 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2025-01-23 | Scavilla Daniel T President, CEO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +140,000 | 140,000 | ||
| 2025-01-23 | TOBIN JAMES R Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2025-01-23 | Wolterman Dan Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2025-01-23 | ZARRILLI STEPHEN T Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2025-01-10 | Pfeil Keith W COO, CFO | Option exercise 10b5-1 | +5,833 | $49.65 | $290K | 5,833 |
| 2025-01-10 | Pfeil Keith W COO, CFO | Option exercise 10b5-1 | +8,334 | $53.27 | $444K | 14,167 |
| 2025-01-10 | Pfeil Keith W COO, CFO | Sale 10b5-1 | −12,501 | $88.17 | $1.1M | 1,666 |
| 2025-01-10 | Pfeil Keith W COO, CFO | Sale 10b5-1 | −1,666 | $89.17 | $149K | 0 |
| 2025-01-10 | Pfeil Keith W COO, CFO | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −5,833 | 0 | ||
| 2025-01-10 | Pfeil Keith W COO, CFO | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −8,334 | 833 | ||
| 2025-01-02 | Davidar David D Director | Gift | −6,100 | 510,175 | ||
| 2024-12-02 | Huller Kelly SVP, GC, Corporate Secretary | Option exercise 10b5-1 | +2,500 | $24.21 | $61K | 2,500 |
| 2024-12-02 | Huller Kelly SVP, GC, Corporate Secretary | Sale 10b5-1 | −2,500 | $87.00 | $218K | 0 |
| 2024-12-02 | Huller Kelly SVP, GC, Corporate Secretary | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −2,500 | 0 | ||
| 2024-11-22 | Davidar David D Director | Sale 10b5-1 | −6,766 | $85.00 | $575K | 516,275 |
| 2024-11-22 | Davidar David D Director | Sale 10b5-1 | −6,746 | $85.00 | $573K | 165,967 |
| 2024-11-22 | Lemaitre Dan Director | Option exercise | +1,097 | $65.05 | $71K | 1,097 |
Page 5 of 10 · 200 trades